Dr. Jamie Berta Spangler

Title of Grant:       Engineered Natural Killer Cell Therapies Targeting Acute Myeloid Leukemia

Description: Acute myeloid leukemia (AML) is a highly prevalent form of blood cancer with extremely low survival rates. Therapies that activate the patient’s immune system to fight disease have been successful in many leukemias, but not AML. We will create a new immune-activating therapy that robustly and safely targets AML.